A new collaboration between NCCN and Flatiron Health will provide the opportunity to analyze key quality and outcomes metrics and identify trends and patterns in the care of patients with cancer.
“The collaboration with Flatiron Health will provide oncology stakeholders the ability to garner critical insights needed to make informed decisions,” said Robert W. Carlson, MD, Chief Executive Officer, NCCN. “This database will give NCCN a leading edge in determining strategies for optimizing treatment protocols, as well as appropriate goals for oncology policy.”
Through this collaboration, electronic health record (EHR) data will be aggregated for cancer quality and outcomes assessment, as well as identification of key trends and patterns in the care of patients with cancer. Within this database, NCCN Member Institutions will have the opportunity to measure concordance to the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) and will be able to access OncoAnalytics™, Flatiron Health’s proprietary, cloud-based analytics tool.
Read the complete press release: http://flatiron.com/about/press/NCCN